Peer Education for School Health Services
(PEER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial evaluates a program designed to boost awareness about the human papillomavirus (HPV) and increase the use of school-based health centers (SBHCs) for health services. The goal is to prevent HPV-related cancers through vaccination and education, thereby improving health. Participants will join either the usual care group or the group receiving additional educational materials and sessions. This trial is ideal for children aged 9-18 who are due for an HPV vaccine and visit SBHCs. As an unphased trial, it offers a unique opportunity to contribute to significant public health research and potentially enhance community health outcomes.
What prior data suggests that this program is safe for increasing HPV vaccination rates?
Research has shown that the HPV vaccine is generally safe for people. The FDA has approved it, and it is widely used to prevent certain cancers caused by the human papillomavirus. Studies have found that educational programs about the HPV vaccine can increase knowledge and vaccination rates. For example, one study found that teaching students about the vaccine in schools improved vaccination outcomes for teenagers, suggesting it is beneficial and safe.
The HPV vaccine is considered safe, with side effects usually being mild, such as soreness at the injection site or a slight fever. Overall, evidence supports the vaccine's safety and effectiveness in preventing diseases related to HPV.12345Why are researchers excited about this trial?
Researchers are excited about the Peer Education for School Health Services trial because it explores a new approach to increasing HPV vaccination rates. Unlike standard methods that rely on routine healthcare provider recommendations, this trial introduces peer-to-peer educational sessions, along with mailers and provider materials, to boost vaccination uptake. This innovative strategy leverages peer influence and direct communication, aiming to make vaccinations more accessible and appealing to school-aged individuals. By focusing on education and social support, this trial could significantly enhance the effectiveness of current vaccination efforts.
What evidence suggests that this trial's treatments could be effective in reducing HPV-associated cancers?
Research has shown that teaching people about HPV (human papillomavirus) through their peers can greatly increase vaccination rates. For example, one study found that when students learned from their peers, more of them decided to get vaccinated. Another study demonstrated that after peer education, students' understanding of HPV improved significantly, with their knowledge scores rising from about 1 to over 23. Additionally, students who participated in peer education programs were more likely to plan on getting vaccinated than those who did not. This trial will compare the standard procedure of HPV vaccination recommendations with an intervention involving peer education. These findings suggest that peer education about HPV can effectively encourage more people to get vaccinated, potentially reducing the risk of HPV-related cancers.16789
Who Is on the Research Team?
Amanda Petrik, PhD
Principal Investigator
Kaiser Permanente
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Intervention components such as mailers, provider materials, and peer-to-peer educational sessions are administered
Follow-up
Participants are monitored for vaccination rates and use of SBHC services
What Are the Treatments Tested in This Trial?
Interventions
- HPV Vaccination
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Intervention components (mailers, provider materials, and peer-to-peer educational sessions) will be administered during the intervention portion of each cluster.
All participating SBHCs offer routine HPV vaccination recommendations as part of clinical care and SBHC staff will continue to follow standard procedures to deliver these services. Further, all SBHCs have existing relationships with the affiliated schools, so the delivery of these healthcare services in the context of schools will not deviate from usual care.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kaiser Permanente
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Citations
The Effectiveness of Interventions Targeting Adolescents in ...
Peer education interventions had promising results in increasing HPV vaccine uptake. Thus, Ferrara et al. reported higher vaccination rates ...
Health belief model–based peer education to improve ...
This randomized controlled trial demonstrated that an HBM-based peer education program significantly improved HPV-related knowledge, perceived benefits, and ...
Peer education on HPV: impact on health sciences students ...
This study showed that structured peer education significantly improved health sciences students' HPV-related knowledge, awareness, and anxiety levels, ...
Effectiveness of a School- and Primary Care–Based HPV ...
This cluster randomized trial examines the effectiveness of a school- and primary care–based multicomponent intervention to increase human ...
Effects of an educational health promotion intervention to ...
Students in the intervention group reported a greater increment in intention to receive HPV vaccination compared to students in the control ...
The effect of peer education on high school students ...
Before peer education, the mean HPV-KS score among students was 1.14 ± 3.54, while after peer education, the mean score increased to 23.78 ± 8.32, and this ...
Effects of an educational health promotion intervention to ...
Outcome measures were participants' uptake of HPV vaccination, intention to receive HPV vaccination, and knowledge and attitudes towards HPV ...
HPV Vaccine Education for Medical Assistants: Impact Study
Results: Post-education data showed improvements in Medical Assistants' perceptions, knowledge, and comfort levels regarding the Human Papillomavirus vaccine.
Human papillomavirus vaccine uptake and the impact of ...
The percentage of 16-year-old girls who received at least one dose of the HPV vaccine increased steadily over the survey periods, from 28.8% in ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.